Skip to content
10-Q

Quarterly Report

BIO-TECHNE Corp TECH

0001104659-26-056302

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · Apr 29, 2026 156.57M sh
Shares Diluted Q3 2026 · Mar 31, 2026 157.4M sh
Shares Diluted Q3 2026 · Mar 31, 2026 156.94M sh
Shares Diluted Q3 2026 · Mar 31, 2025 158.94M sh
Shares Diluted Q3 2026 · Mar 31, 2025 160.66M sh
Stock Repurchased Q3 2026 · Mar 31, 2026 $24K
Stock Repurchased Q3 2026 · Mar 31, 2025 $175.67M
Dividends Paid Q3 2026 · Mar 31, 2026 $37.43M
Dividends Paid Q3 2026 · Mar 31, 2025 $38M
Capex Q3 2026 · Mar 31, 2026 $20.37M
Capex Q3 2026 · Mar 31, 2025 $26.12M
Operating Cash Flow Q3 2026 · Mar 31, 2026 $196.66M
Operating Cash Flow Q3 2026 · Mar 31, 2025 $189.36M
Cash And Equivalents Q3 2026 · Mar 31, 2026 $209.82M
Cash And Equivalents Q3 2026 · Jun 30, 2025 $162.19M
Stockholders Equity Q3 2026 · Mar 31, 2026 $2.09B
Stockholders Equity Q3 2026 · Jun 30, 2025 $1.92B
Current Liabilities Q3 2026 · Mar 31, 2026 $153.28M
Current Liabilities Q3 2026 · Jun 30, 2025 $175.85M
Current Assets Q3 2026 · Mar 31, 2026 $688.05M
Current Assets Q3 2026 · Jun 30, 2025 $608.3M
Total Assets Q3 2026 · Mar 31, 2026 $2.55B
Total Assets Q3 2026 · Jun 30, 2025 $2.56B
Eps Diluted Q3 2026 · Mar 31, 2026 $0.32
Eps Diluted Q3 2026 · Mar 31, 2026 $0.81
Eps Diluted Q3 2026 · Mar 31, 2025 $0.14
Eps Diluted Q3 2026 · Mar 31, 2025 $0.57
Eps Basic Q3 2026 · Mar 31, 2026 $0.33
Eps Basic Q3 2026 · Mar 31, 2026 $0.82
Eps Basic Q3 2026 · Mar 31, 2025 $0.14
Eps Basic Q3 2026 · Mar 31, 2025 $0.58
Sga Expense Q3 2026 · Mar 31, 2026 $109.34M
Sga Expense Q3 2026 · Mar 31, 2026 $339.24M
Sga Expense Q3 2026 · Mar 31, 2025 $151.27M
Sga Expense Q3 2026 · Mar 31, 2025 $391.88M
Net Income Q3 2026 · Mar 31, 2026 $51.05M
Net Income Q3 2026 · Mar 31, 2026 $127.24M
Net Income Q3 2026 · Mar 31, 2025 $22.59M
Net Income Q3 2026 · Mar 31, 2025 $91.08M
Operating Income Q3 2026 · Mar 31, 2026 $75.5M
Operating Income Q3 2026 · Mar 31, 2026 $177.61M
Operating Income Q3 2026 · Mar 31, 2025 $38.71M
Operating Income Q3 2026 · Mar 31, 2025 $126.12M
Gross Profit Q3 2026 · Mar 31, 2026 $208.29M
Gross Profit Q3 2026 · Mar 31, 2026 $587.68M
Gross Profit Q3 2026 · Mar 31, 2025 $214.56M
Gross Profit Q3 2026 · Mar 31, 2025 $591.46M
Cost Of Revenue Q3 2026 · Mar 31, 2026 $103.13M
Cost Of Revenue Q3 2026 · Mar 31, 2026 $306.17M
Cost Of Revenue Q3 2026 · Mar 31, 2025 $101.63M
Cost Of Revenue Q3 2026 · Mar 31, 2025 $311.21M
Revenue Q3 2026 · Mar 31, 2026 $311.42M
Revenue Q3 2026 · Mar 31, 2026 $893.85M
Revenue Q3 2026 · Mar 31, 2025 $316.18M
Revenue Q3 2026 · Mar 31, 2025 $902.67M